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Summary 
The ~'-family dimers (~', 7/, and 3,) are a group of structurally and functionally related proteins 
that are expressed in developing thymocytes and function as signal transducing subunits of the 
T cell antigen receptor (TCR) and certain Ig Fc receptors. ~', ~/, and 3' each contain one or more 
copies  of a conserved tyrosine-based activation motif (TAM) that is known to be required for 
signal transduction. To examine the developmental importance of multiple or individual TAM 
elements we generated transgenic mice that express:  (a) full-length (FL) ~'-chain (3 TAMs); (b) 
~/-chain, a naturally occurring variant of ~" that is derived from alternative splicing (2 TAMs); 
or (c) truncated ~'-chain (CT108;  1 TAM), under the control of the human CD2 promoter and 
regulatory elements. Unexpectedly, we found that overexpression of the FL ~'chain caused premature 
termination of RAG-1 and RAG-2 expression, prevented productive rearrangement of the TCR- 
and TCR-B genes and blocked entry of thymocytes into the CD4/CD8 developmental pathway. 
In contrast, we found that overexpression of ~/or CT108 had no effect on normal thymocyte 
maturation. These results suggest that an early signaling pathway exists in precursor TCR- 
thymocytes that can regulate RAG-1 and RAG-2 expression and is differentially responsive to 
individual members of the ~'-family dimers. 
T 
he ~'-family dimers are a group of structurally and func- 
tionally related proteins that play a central role both in 
receptor surface expression and signal transduction. Members 
of the ~'-family currently include ~" (1), its alternatively spliced 
form, 7/, (2) and the 3' chain subunit of the high affinity IgE 
receptor, FceR.I (3). The ~" chain was first discovered as a com- 
ponent of the multimeric TCR complex (4).  The TCR is 
now known to be composed of at least seven subunits that 
fall into three distinct groups: (a) the disulphide-linked dono- 
typic subunits (c~//~ or 3,/~) which are the products of de- 
velopmentally programmed gene rearrangements and confer 
ligand binding specificity (5); (b) the invariant CD3 chains, 
3,,/~, and e, which assemble as noncovalently linked hetero- 
dimers (6); and (c) a disulphide-linked homo- or heterodimer 
composed of one or more members of the ~'-family of pro- 
teins (7). 
~'-family dimers are required for targeting expression of 
the TCR (8) as well as at least two other receptor complexes, 
FcyRIII (CD16)  (9,  10) and FceRI (3) to the cell surface. 
The assembly, transport, and surface expression of these recep- 
tor complexes is dependent upon sequences that reside exclu- 
sively within the charged transmembrane domains of their 
respective subunits (10,  11). ~'-family dimers also function 
to couple the TCR (8,  12) as well as other lymphocyte cell 
surface molecules (Thy 1, Ly-6, CD2) (12-14)  to a complex 
signal transduction pathway that involves mobilization of in- 
traceilular calcium stores, activation of protein kinase C, and 
activation of cytoplasmic protein tyrosine kinases (4, 15). Con- 
served sequences (termed tyrosine-based activation motifs; 
[TAMs] 1) within the cytoplasmic domains of the ~', 7/, and 
FceRI3, chains are required for signal transduction (13, 16-19). 
TAM elements, which consist of a pair of tyrosines separated 
by 10 or 11 amino acids, are also present in the cytoplasmic 
domains of several other transmembrane proteins known or 
thought to function in signal transduction, including the CD3- 
3',  -~ and -e chains, and the ~  subunit of the high affinity 
IgE receptor (13,  18, 20). Within this group, the ~" and ~/ 
chains are unique in that they contain multiple TAMs: 3 or 
2 respectively.  The functional significance of the individual 
TAM elements or of multiple TAMs is still unknown. In 
T  hybridoma lines,  the presence of a single TAM, either in 
1 Abbreviations used in this paper: DP, double positive; FCM, multicolor 
flow cytometer;  FL, full-length;  SP, single  positive; TAM, tyrosine-based 
activation motif; Tg, transgenic; TRA, Texas Red Avidin. 
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brane chimeras, is both necessary and sufficient to mimic TCK 
effector functions (12, 13, 17, 18, 21). In addition, truncated 
~" chain variants that are devoid of TAM elements but retain 
the transmembrane domain are capable of reconstituting sur- 
face expression of functional TCK complexes (as assessed by 
ligand binding or antibody-mediated cross-linking) (13). These 
observations indicate that TAMs within the CD3 chains can 
function as autonomous signaling modules in the absence 
of ~'-~" dimers. 
Although considerable insight has been gained regarding 
the function of ~" and related molecules in established T cell 
lines,  their  role  in  thymocyte development has  not  been 
specifically addressed.  The TCR complex regulates thymo- 
cyte development by initiating specific signal  transduction 
events at appropriate stages in ontogeny. TCIk-mediated sig- 
naling in immature CD4+CD8 + thymocytes can result in 
either the deletion of self-reactive clones (negative selection) 
or their further maturation (positive selection) (22, 23). TCR 
signals also function to fix the specificity of  individual thymo- 
cytes by terminating expression of the recombination activating 
genes, RAG-1 and RAG-2 (24).  An intrinsic potential for 
variability in the TCR-directed signaling response derives not 
only from the clonotypic nature of the TCR (conferred by 
the ot/~ or 3,/di chains) but also from the ability of the TCR 
to assemble into distinct isoforms by association of the otlSyde 
core  with  various permutations  of ~'-family dimers,  e.g., 
ot/~V~e-~'~', ot/3"yc3e-~'~, cr/~7r  y  .  .  . etc.  (7).  Whether 
or not different members of the ~'-family dimers transduce 
quantitatively or qualitatively distinctive TCR signals  that 
affect thymic development is presently unclear. 
To address this question, we generated transgenic mice that 
expressed a full-length (FL) ~" chain, r/chain, or a truncated 
~'chain variant (CT108) that lacks the COOH-terminal half 
of the cytoplasmic domain (12). Thus, the transgene encoded 
proteins contained 3, 2, or 1 TAMs, respectively.  We found 
that overexpression  of FL ~" caused a dose-dependent arrest 
of thymocyte maturation characterized by incomplete rear- 
rangement of the TCR-ot and TCR-/~ genes, whereas over- 
expression of r/or CT108 did not preceptibly alter the normal 
thymocyte  developmental program. Furthermore, overexpres- 
sion ofFL ~'chain resulted in premature termination of RAG-1 
and RAG-2 expression and upregulation of CD2 and CD5 
in CD4-CDd-  TCR- fetal thymocytes. Collectively,  these 
results suggest that a TCR-independent signal transduction 
pathway  functions  in  early  thymocyte precursors  and  is 
differentially  responsive to individual members of the ~'-family 
dimers. 
Materials and Methods 
DNA Constructs  andMicroinjection.  ~'-FL  and ~'-CT108 minigenes 
were generated by ligating a 350-bp EcoR1-Accl cDNA fragment 
(containing exons I-Va) from either plasmid pSVL-~'or  pSVL-CT108, 
respectively (12), with a 4.2-kb Accl-BamH1 genomic DNA frag- 
ment encoding ~" exons Va-VIII (reference 25;  Fig. 1).  The  r/ 
minigene was constructed using a PCR-generated EcoR1-Sall frag- 
ment that contained  the complete ~ cDNA coding sequences. Trans- 
gene constructs were then made by replacing the EcoR1-BamH1 
fragment in construct CD2-B (which contained  human CD2 coding 
sequences; reference 26) with the ~'-FL, ~'-CT108, or r/minigene 
fragments. After digestion with Sall and Not1, transgene DNA 
was separated from vector sequences by electrophoresis, extracted 
from agarose gel slices and resuspended  in TE buffer (10 mM Tris, 
pH 7.4; 0.1 mM EDTA) at a final  concentration of 5 ng//~l. Fertil- 
ized oocytes  were obtained  from inbred FVB/N mice and pronuclear 
injection was performed essentially as described (27). 
Antibodies and Reagents.  Anti-FcyR.II/III mAb (2.4G2) (28) 
was provided byJ. Titus (National Institutes of Health, [NIH]). 
FITC anti-CD5 mAB (52-7.3), biotin anti-CD8 mAb (53-6.72), 
and negative control (anti-human) mAbs (FITC-Leu-4  and biotin- 
Leu-4) were obtained from Becton Dickinson Immunocytometry 
Systems (Mountain View, CA). FITC-conjugated  anti-TCR.~  (GL3) 
mAb, anti-CD4 (RM4.5), and anti-CD2 mAb (RM2-5), as well 
as biotin-hamster anti-mouse CD3 (500.A2) were purchased from 
PharMingen (San Diego, CA). Hamster anti-mouse CD3 mAb 
(145-2Cll) (29) and hamster anti-mouse TCR-/8 mAb (H57-597) 
(30) were purified from culture supernatant and conjugated as re- 
quired in our laboratory. Texas red-conjugated streptavidin (TRA) 
(red fluorescence)  was purchased from Bethesda Research Labora- 
tories (Gaithersburg, MD). Anti-~"  antibodies 528 and 551 were 
generously provided by A. M. Weissman (NIH). Antibody 528 
was generated in a rabbit to a peptide that corresponded to amino 
acids 88-101 of murine ~" and recognizes  both the ~" and r/proteins 
(31); antibody 551 was generated to a peptide that corresponded 
to amino acids 151-164 and recognizes only ~" protein. 
MulticolorFlowCytometry(FCM).  Thymocytes were stained at 
4~  and washed  with Hanks balanced salt solution  containing  0.5% 
bovine serum albumin and 0.5% sodium azide. In general, cells 
were first incubated with anti-FcR mAb 2.4G2 to prevent non- 
specific binding of conjugated mAbs. For two-color FCM studies, 
cells were incubated with FITC-labeled mAbs for 30--40 rain, 
washed 3 x, and then incubated with biotinylated mAbs for 30-40 
rain. The antibody-labeled  cells were washed 3 x, followed  by the 
addition of TRA-streptavidin for 10 min. Cells were then washed 
3 x and analyzed by FCM. Multicolor FCM was performed using 
a modified  Dual-Laser  FACStar  PLUS  |  or FACS  II  |  (Becton Dick- 
inson Immunocytometry  Systems)  equipped with the manufacturer's 
filters and photomultiplier tubes, argon ion laser for FITC excita- 
tion (488 nm), pumped dye (rhodamine 6C) laser for Texas red 
excitation (590 nm), and interfaced to a DEC MVAX 3500 (Dig- 
ital Equipment Corporation, Marlboro, MA). All fluorescence  anal- 
yses were performed by using logarithmic amplification  (3-decade 
or 4-decade, as indicated), and data were collected and analyzed 
using hardware and software designed by the Division of Com- 
puter Research and Technology  at the NIH. Fluorescence  data were 
collected on 5-25  x  104 viable cells, as determined by electronic 
gating on forward light scatter and propidium iodide exclusion. 
Electronically-gated data were then collected in matrix form on 
1-10  x  104 cells within the live gate. 
Preparation of CD3/TCR-  Thymocytes.  Total  thymocytes  were 
coated with hamster anti-CD3 mAb (145-2Cll superuatant)  at 4~ 
for 30 rain and then washed 2 x in Hanks-buffered  saline  plus 10% 
FCS. CD3-coated cells were then allowed to adhere to plastic plates 
coated with anti-hamster  Ig (Fabz) at room temperature in the 
presence of sodium azide to prevent receptor internalization.  Nonad- 
herent cells were found to be >95% CD3 (145-2Cll)-  and TCR 
(H57-597)-  by FCM. 
Protein  Anal)sis.  For immunoblots,  whole-cell  lysates  of  enumer- 
ated thymocytes were prepared as described (32). After electropho- 
resis, proteins were transferred to nitrocellulose and blotted with 
the appropriate ~'antisera  at a 1:200 dilution. Immunoreactive  pro- 
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tibody conjugated to alkaline phosphatase,  by chemiluminescence 
using the Western Light system (Tropix Inc., Bedford, MA). For 
metabolic labeling,  100  x  106 thymocytes were labeled for 30 rain 
with [3SS]methionine  (Tran.3SS.label, final concentration  1 mCi/ml; 
ICN Biomedicals Inc., Costa Mesa, CA) in methionine-free KPMI 
plus 10% fetal calf serum. Labeled cells were washed  in PBS and 
lysed at 4~  in buffer containing 1%  NP-40, 0.15 M  NaC1,  50 
mM  Tris-HCl  (pH  7.4),  20  #g/ml  leupeptin,  and  40  #g/ml 
aprotinin. Lysates were then incubated at 4~  overnight in the pres- 
ence of anti-~" antiserum 528 and protein A-Sepharose.  Immuno- 
precipitated samples were washed 3 x  in lysis  buffer containing 0.2% 
NP-40, solubilized by boiling for 5 min in nonreducing SDS loading 
buffer and analyzed by two-dimensional SDS-PAGE (13%) and au- 
toradiography. 
RNA  Extraction  and Analysis.  Thymocyte RNA was extracted 
as described (33).  cDNA probes for Cot (34),  C3 (35),  C'y (36), 
and C/~ (37) were provided by E. Shevach (NIH), probes for CD3y 
(38), CD36 (39) and CD3e (40) were provided by M. Wilkenson 
(Oregon Health Sciencies University, Portland, OR); RAG-1 (41) 
and RAG-2 (42) probes were provided by D. Schatz (Yale Univer- 
sity School of Medicine,  New  Haven,  CT);  and  ~" cDNA  and 
genomic clones (1, 25) were provided by R. Klausner (NIH). Human 
~-actin and GAPDH cDNAs were purchased from Clontech Labora- 
tories Inc.  (Palo Alto,  CA).  Probes  were labeled  with 32p using 
the random primer method (43). 
Results 
Transgene  Construction.  The transgenes generated in these 
experiments were designed to express either the FL ~" chain 
or  ~" chain  variants  with  only 2  or  1 TAM  functional ele- 
ments (Fig. 1). To produce FL ~'chain, a minigene was created 
by fusing the 5' portion of the murine ~" cDNA  (encoding 
exons I-V) with genomic sequences encoding exons VI-VIII 
(1,  25;  see Fig.  1).  The assembled minigene  therefore con- 
tained introns V-VII  and the native polyadenylation signal 
(25).  The  ~'-CT108  minigene  was  made  by replacing  the 
cDNA fragment with an otherwise identical sequence that 
contained an inframe termination  codon (TAA) in place of 
Glu ws (Fig.  1 A).  Consequently,  this construct  should  di- 
rect the synthesis of a truncated  ~" chain that lacks residues 
109-164  of the  cytoplasmic domain  and  contains  only the 
first  TAM  (12)  (Fig.  1  B).  The  ~/  minigene  was  made by 
replacing the ~" cDNA fragment with the complete coding 
sequences from murine ?7 cDNA (2; Fig. 1 A). As illustrated 
in Fig.  1 B, 7/chain differs from ~" only in its distal COOH- 
terminal domain such that the third TAM, as well as a puta- 
tive nucleotide binding site (1), is destroyed. The assembled 
minigenes were inserted into the human CD2 promoter/en- 
hancer cassette which  has been  shown  previously to direct 
high level, T  lineage-specific expression of transgenes in mice 
(26).  Transgenic mice were generated by microinjection of 
constructs  into  embryos obtained from inbred  FVB/N  fe- 
males. A  total of seven ~'-FL,  six ~'-CT108,  and six 7/trans- 
genic founder lines were obtained and subsequently analyzed. 
Expression  of the ~'-FL, ~'-CT108,  and ~l Transgenes.  Trans- 
gene expression was quantitated by hybridizing Northern blots 
of total thymocyte RNA  from control and transgenic mice 
with a probe derived from 5' ~'/7/cDNA sequences spanning 
exons I-V (Fig. 2). When compared with the level of endog- 
Figure  1.  (A) ~'-FL, ~'-CT108, and ~ transgene constructs. Promoter- 
less ~', CT108, and ~ minigenes  were  placed  under the control of  the human 
CD2 promoter and 3' regulatory sequences  (grey boxes) (26). Blach boxes 
represent ~"  cDNA, ~ cDNA, or ~"  exons; lines represent  introns. The loca- 
tion of the Glu ~  Stop mutation within construct .('-CT108  is indicated 
by the arrow. S, Sall; N, Not1 sites. (B) Schematic  representation  of the 
~'-FL, ~'-CT108,  and "r/chains.  The extracellular  (EC), transmembrane  (TM), 
and cytoplasmic  domains are depicted  as black, shaded, or open boxes, respec- 
tively. The striped box at the Y-terminus of ~-chain indicates the unique 
region generated  by alternative  splicing. The location  of  TAMs, a-c within 
the cytoplasmic  domains of transgenic proteins is indicated. Y, tyrosine 
residues. Note that the third TAM is destroyed  by alternative splicing in 
?7 chain. 
Figure  2.  Quantitation  of 
~'-FL, ~/, and ~'-CT108 transgene 
expression. 10 #g of total RNA 
from thymus was electrophoresed 
through a formaldehyde/agarose 
gel, transferred to nylon mem- 
branes, and  hybridized with  a 
probe derived from the ~" coding 
region  (top) or  with  a  probe 
specific to the 5'-untranslated re- 
gion  of endogenous ~" mRNA 
(bottom). The levels of transgene 
expression  relative  to endogenous 
~" (determined by densitometry) 
are shown in parentheses. Non- 
Tg, nontransgenic littermate. 
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2 to  12x  in ~'-FL lines,  1.5  to  10x  in ~'-CT108  lines, and 
1 to 10x  in ~ lines. In addition, probing of Northern blots 
with an oligonucleotide specific for the 5' untranslated re- 
gion of endogenous ~" mRNA demonstrated that the level 
of endogenous  ~" transcripts  was unaffected (Fig.  2). 
In thymocytes from ~'-FL transgenic lines, the amount of 
~" protein was increased and was commensurate with levels 
of transgene-encoded  ~" mKNA (Fig. 3 A).  In addition,  ~" 
chains assembled as disulphide linked ~'-~"  homodirners of 32 
kD as they did in nontransgenic mice; however, the highest 
expressing ~'-FL transgenic lines also contained detectable quan- 
tities of unassembled ~" monomers of 16 kD (Fig. 3 A).  In 
thymocytes from ~'-CT108 and ~/transgenic mice, transgene 
expression was determined by immunoprecipitating metabol- 
ically labeled  material with antisera  528  that was directed 
against a transmembrane-proximal peptide common to the 
~', CT108, and ~? proteins (31). Resolution ofimmunoprecipi- 
tares on two-dimensional nonreducing/reducing SDS-PAGE 
revealed proteins of the predicted size for CT108 (10 kD) (12) 
and 7/(23 kD) (2, 31),  as well as the presence of all possible 
dimeric forms between CT108  and endogenous  ~', and be- 
tween r/and endogenous ~" (Fig. 3 B). Immunoprecipitation 
of intact TCKs with anti-CD3e  (mAB  145-2Cll)  revealed 
that each of these dimeric forms also assembled with the other 
TCR  subunits  into  complete  TCtL  complexes  (data  not 
shown). 
Overexpression of FL ~" chain Alters Normal Thymocyte De- 
velopment.  The effects of transgene expression  on thymo- 
cyte development were assessed by immunofluorescence and 
FCM (Fig. 4). In contrast to overexpression of CT108 or 7/, 
neither of which inhibited thymocyte maturation at any ex- 
pression level, overexpression of FL ~" chain had a strikingly 
inhibitory effect on thymocyte maturation (Fig. 4) as evidenced 
by:  (a)  decreased  thymus  size  and  cellularity;  (b)  reduced 
numbers  of both  immature  CD4 +CD8 +  (double positive 
[DP])  thymocytes  and  mature,  CD4+CD8 -  and  CD4- 
CD8 + (single positive [SP])  thymocytes, and most notably, 
(c)  reduced  numbers  of TCR +  o~/~/ thymocytes (Fig.  4). 
The degree of maturational arrest correlated with transgene 
dosage  as  thymic cellularity and  numbers  of TCR +  o~/B 
thymocytes decreased with increasing ~"  chain expression (Fig. 
4).  The highest expressing (10-12x)  ~'-FL transgenic lines 
were essentially devoid of mature SP thymocytes and TCR + 
Figure 3.  Overexpression  of~', CT108, and T/chains  in transgenic  thymo- 
cytes. (A) Immunoblot of thymocyte whole cell lysates (5  x  106/lane) 
from ~'-FL  transgenic  mice and a Non-Tg  littermate resolved  by 12% SDS- 
PAGE under nonreducing  conditions.  Blotting was performed  with anti-~" 
antibody 551. The positions of the 32-kD ~'-~"  homodimer and 16-kD 
~"  chain  monomer  are indicated.  Values  in parentheses  are estimates  of trans- 
gene expression relative to endogenous  ~" chain and are based on densito- 
metric scanning. (B) Two-dimensional  nonreducing/reducing  SDS-PAGE 
(13%) of anti-~"  (antibody  528) immunoprecipitates  from Non-Tg, ~/trans- 
genic (line  C5160; 5x), and ~'-CT108 transgenic  (line  C983; 10x) thymo- 
cytes.  Migration  positions  of ~'-~', ~'-CT108 (CT), CT108-CT108 (CT--CT), 
~'-~/, and ~/-T/dimers are indicated. 
Figure 4.  Overexpression  of FL ~" but not CT108 or ~? chain results 
in thymocyte  maturational  arrest. Thymocytes  from Non-Tg  controls, trans- 
genic lines  expressing  varying  levels  of  the FIc~'-chain,  or from representa- 
tive ~'-CT108 and ~/transgenic lines were stained and analyzed  by two- 
color FCM (column 1) or one-color FCM (columns  2 and 3). Transgene 
expression relative  to endogenous  ~" chain (as assessed  by Northern anal- 
ysis) is indicated  within parentheses. Two-color  histograms  show staining 
of thymocytes  with FITC anti-CD4 vs. biotin anti-CD8 plus TRA. The 
frequency  of CD4- CD8 +, CD4 +  CD8 +, and CD4 +  CD8 -  thymocytes 
are indicated  in their respective  quadrants. Total numbers of thymocytes 
are also shown. Single  color histograms  were obtained by staining with 
FITC anti-TCR-3 (column  2) or FITC anti-CD5 (column  3). Shaded  areas 
indicate staining with control antibody (FITC-Leu  4). 
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SP gates in these transgenic lines were CD4  l~ or CD81~ and 
represent immature transitional cells that are the immediate 
precursors  of DP  thymocytes (44).  The  unique  inhibitory 
effects of ~" overexpression cannot be attributed to the integra- 
tion site of the ~'-FL transgene as similar maturational defects 
were observed in multiple, independently derived transgenic 
lines (Fig.  4). In addition,  since all of the transgenes use the 
same dominant control element (Fig.  1), nonspecific effects 
such as variable onset of expression or competition for tran- 
scription factors could not account for the differential effects 
of ~'-FL, ~'-CT108,  and ~/transgenes.  Thus,  overexpression 
of the FL ~" chain, but not structurally related molecules such 
as CT108 or 7/, specifically  inhibited both the generation of 
TCR + c~//3 thymocytes and the maturation  of thymocytes 
along  the  CD4/CD8  pathway. 
Whereas overexpression of CT108 and the */-chain  were 
not inhibitory, they did affect TCR ct/~ expression in that 
thymocytes from ~'-CT108 and 7/transgenic lines had increased 
amounts ofTCR ol/~ complexes (Fig. 4, column 2). Similar 
results have been reported previously for transgenic mice in 
which ~/was expressed under control of the Thy-1 promoter 
and regulatory elements (45). In fact, thymocytes from lower 
expressing  (2-5 x)  ~'-FL transgenic  lines  also exhibited in- 
creased TCR o~//3 expression (Fig.  4). Therefore, CT108, 7/, 
and ~" all facilitate increased surface expression of TCR com- 
plexes on developing thymocytes, but only ~" overexpression 
results in developmental arrest and paradoxical loss of TCR 
expression with  increasing  transgene  dosage. 
Transgene Dose-related  Suppression of TCR ~  and TCR-~ Gene 
Rearrangements in ~'-FL Transgenic Thymocytes.  The inhibi- 
tory effects of FL ~" chain overexpression on surface TCR ct/~ 
expression were entirely unexpected. To understand the mo- 
lecular basis for decreased TCR or//3  expression we deter- 
mined  the  abundance  of TCR  subunit  transcripts  in  total 
thymocyte RNA from  ~'-FL transgenic  mice. Whereas  the 
levels of CD3-% -/~, and -e transcripts  were the same in thymo- 
cytes from ~'-FL transgenic and nontransgenic mice (Fig.  5, 
right),  the amount  of mature TCR-ol (1.7 kb)  and mature 
TCR-/3 (1.3 kb) transcripts were markedly decreased and were 
inversely related to transgene dosage (Fig.  5,  left).  Because 
adult thymi from the highest copy number ~'-FL transgenic 
mice  were  essentially  devoid  of TCR +  ct/B  thymocytes, 
we compared the abundance of TCR-o~ and TCR-B trans- 
cripts  in  transgenic  thymocytes to  isolated populations  of 
TCR-  thymocytes from nontransgenic mice. In the highest 
copy number transgenic lines,  the amount of mature,  1.7 kb 
(V~-J~-C~)  and  mature,  1.3  kb  (V~-Da-Ja-C~)  transcripts 
were greatly reduced in comparison to TCR-  nontransgenic 
thymocytes (Fig.  5). In addition, the TCP,-/3 transcripts that 
were present in the 8-12 x  transgenic lines were composed 
predominantly  of immature,  1.0-kb  (D~-Ja-C~)  mRNAs. 
Conversely, relative amounts of TCR-3, and TCR-/~ trans- 
cripts increased with increasing transgene expression,  approach- 
ing the levels observed in TCR-  nontransgenic thymocytes. 
Thus,  overexpression of ~" protein  specifically  inhibited  ap- 
pearance of mature TCR-ol and mature TCR-B transcripts. 
Because decreased amounts of mature TCR-ot and TCR-/3 
transcripts  might have resulted from decreased gene rearrange- 
ments, we blotted HindlII- or EcoRI-digested total thymo- 
cyte DNA from nontransgenic and ~'-FL transgenic  mice with 
Figure 5.  TCR-ct  and -~ transcripts are reduced in ~'-FL transgenic 
thymocytes. 5 /~g of thymocyte RNA from the indicated sources was 
resolved  by formaldehyde/agarose  electrophoresis,  transferred  to nylon  mem- 
branes and hybridized with radiolabeled  probes derived from the various 
TCR or CD3 cDNAs. Radiolabeled  human B-actin cDNA (Clontech 
Laboratories, Inc.) was used  as a control to assess  equal  loading. (Left)  Com- 
parison of TCR gene expression  in total (lane 1) or TCR- (lane  2) non- 
transgenic thymocytes  with ~'-FL  transgenic thymocytes  (lanes 3-5). Rel- 
ative transgene expression  is indicated  in parentheses. For TCR.-o~,  -/3, and 
-g, the sizes of both the mature (larger) and immature (smaller) mRNA 
species  are indicated. (Right)  Comparison of CD3-'t/~/e and ~" transcripts 
in control (Non-Tg; lane 1) and ~'-FL  transgenic (lanes 2-4) thymocytes. 
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Figure 6.  Incomplete  rearrangement of the TCIL-a and TCR-fl genes 
in ~'-FL  thymocytes. 10 ~g of total genomic  DNA isolated  from the indi- 
cated sources  was digested  to completion  with HindlII or EcoR1  and ana- 
lyzed  by Southern blotting with probes  that detect rearrangements of the 
TCR-fl (Cfll) (47) or the TCR-ot or TCR-6 (3']~1) (46) loci. The Cfll 
probe detects two germline HindlII fragments: a 9.4-kb Cfll-containing 
germline band that changes in length after V-D-J rearrangement and a 
3.0-kb Cfl2-containing  band that is unaltered by V-D-J  rearrangement and 
serves  as a control for DNA loading and blotting dficiency.  The germline 
configuration of the TCR-, and TCR-~ loci is represented  by a 7.5-kb 
EcoR1 fragment. The unique bands present in thymocytes  from ~'-FL  (8 
and 12 x) mice most likely represent D~-D~ or D~-]6 rearrangements. Figure 7.  Decreased  expres- 
sion  of RAG-1  and RAG-2 in 
~'-FL  transgenic thymocytes. Nor- 
them analysis  was performed with 
1/zg total thymocyte RNA as de- 
scribed in Fig. 5, legend. Probes 
consisted of the FL RAG-1 (41) 
and  RAG-2  (42)  cDNAs  or 
human B-actin cDNA. Exposure 
times  were  24  h  (RAG-1  and 
fl-aetin)  or 72 h  (RAG-2). 
probes  that  specifically detect rearrangements  of the TCR 
c~/~ (46)  and TCR-3  (47) loci. Germline C~1 (9.4 kb) and 
Jel (7.5 kb) bands were present in thymocytes from high ex- 
pressing ~'-FL transgenic mice but not thymocytes from con- 
trol littermates  (Fig.  6), indicating that a high proportion 
of TCR-3  and TCR-cr  loci have not  fully rearranged. 
Reduced Levels of  RAG-1 and RAG-2 Transc@ts  in ~'-FL ~ans- 
genic Thymocytes.  To understand the failure of the TCR-c~ 
and TCR-3 genes to fully rearrange in thymocytes from high 
expressing  ~'-FL transgenic mice,  we examined transgenic 
thymocytes for the presence of mRNAs encoding products 
of the recombination activating genes RAG-1  and RAG-2 
(41,  42),  upon which TCR  gene rearrangements  are criti- 
cally dependent (48, 49). Interestingly, RAG-1  and RAG-2 
transcripts were reduced in adult thymocyte populations from 
5-12 x  ~'-FL transgenic mice relative either to total thymo- 
cytes or to isolated immature TCR-  thymocyte populations 
from nontransgenic control mice (Fig. 7). In addition, RAG-1 
and RAG-2 levels were inversely related to transgene dosage 
(Fig. 7).  Thus overexpression of FL ~" resulted in decreased 
expression of RAG-1 and RAG-2 in developing thymocytes. 
Evidence  for Activation of  an Early Signaling Pathway in ~'-FL 
Transgenic  Mice.  TCR-mediated  signaling  in  immature 
thymocytes is known to result in the rapid disappearance of 
RAG-1  and RAG-2  transcripts  (24).  Since ~" can transduce 
intracellular signals that mimic TCR engagement (13, 16-18), 
we thought that the unique inhibitory effects of ~"  chain over- 
expression might be a consequence of signaling in early thymo- 
cytes.  To assess this possibility, we analyzed thymocytes for 
expression of surface markers that are specifically upregnlated 
in response to TCR-directed  signaling.  For example, CD5 
surface expression is increased in response to either TCK cross- 
linking or TCR-mediated intrathymic selection events (50, 
51). Accordingly, during normal thymocyte development, sur- 
face CD5 expression parallds that of surface TCK expression 
(52)  such  that  CD3 l~ thymocytes  are  CD51~  and  CD3  hi 
thymocytes are CD5 hi (Fig. 8, left). In contrast to the con- 
cordant expression of TCK and CD5 on normal thymocytes, 
thymocytes from ~'-FL transgenic mice were predominantly 
CD5  hi despite absence of TCR  expression (Figs.  4  and 8). 
Moreover,  high expression of CD5  on TCK-  thymocytes 
was unique to thymocytes from ~'-FL transgenic mice as it 
was  not  observed  on  TCR-  thymocytes  from  normal, 
SCID,  ~'-CT108  transgenic,  or ~  transgenic mice (Fig.  8). 
~'-FL  transgenic  CD4-CD8-CD3-  thymocytes  also  ex- 
pressed inappropriately high levels of another known signaling 
molecule, CD2 (Fig.  8) which normally is not expressed at 
high levels on the cell surface until after complete Va(D~)J~ 
rearrangement (53).  Taken together, these data indicate that 
thymocytes from ~'-FL transgenic mice have undergone in- 
trathymic signaling events despite the absence of TCR ol/~/ 
expression. 
Overexpression of  FL ~" Chain Interferes with a Defined Stage 
of  Fetal Thymocyte Development.  To determine at what point 
in thymic ontogeny the inhibitory effects of ~" chain overex- 
pression were first evident,  we examined thymocytes from 
normal and ~'-FL transgenic fetal mice. Maturational defects 
in fetal thymocytes from ~'-FL transgenic mice, as assessed 
by decreased thymic cellularity and decreased numbers of DP 
thymocytes, were evident as early as fetal day 16, but were 
most pronounced on days 17 and 18 of fetal development (Fig. 
CD3 
TOTAL 
CD5 
TOTAL  r  CD4-  CD8"  CD3" 
I  ~  SCID  ~ FL J  ~Non  T  O  CT108  i  ~  Non Tg  CT108  ] 
CD5  CD5  CD2 
Figure 8.  Elevated  CD5 and CD2 expression 
on ~'-FL  thymocytes. In the two-color contour plot 
(panel I), thymocytes from adult, Non-Tg FVB/N 
mice were stained with FITC anti-CD5 vs. biotin 
anti-CD3 plus TRA to demonstrate  the normal 
relationship between CD5 and TCR surface ex- 
pression. In the one-color histograms, total thymo- 
cytes from Non-Tg,  ~'-FL  (10x) transgenic,  ~'-CT108 
(10x) transgenic, ~/(10x) transgenic, and SCID 
mice were stained with FITC-anti-CD5 or FITC-anti-CD2. Shaded area represents staining with control antibody, FITC anti-Leu 4. Pand 2 shows 
CD5 expression on total  thymocytes from SCID,  Non-Tg, and ~'-FL thymocytes. Panels  3  and 4 show CD5 and CD2 expression, respectively, on 
CD4-CD8-TCR- thymocytes from Non-Tg, ~'-FL (10x), CT108 (10x), and ~/(10x) mice. To specifically  examine CD4-CD8-TCK- thymocytes, 
total  thymocytes were sequentially stained with FITC anti-CD5 (Panel 3) or FITC anti-CD2 (panel 4) followed by a mixture of biotin anti-CD4, 
biotin anti-CD8, and biotin anti-CD3 plus TRA. CD5 and CD2 expression on CD4-CDS-TCR-  thymocytes was then examined by computer- 
gating on biotin-TRA-negative  cells. 
1490  ~'-mediated  Signals in Early Thymocyte Development 9 A). Interestingly, although transgene expression begins on 
or before day 15 of fetal life, RAG-1 and RAG-2 transcripts 
were initially high and comparable to those in nontransgenic 
thymocytes on fetal days 15 and 16 but decreased sharply on 
fetal days 17 and 18 and were essentially absent at birth (Fig. 
9 B). Atypical CD5hiTCK -  fetal thymocytes were also first 
detected on fetal day 17 (Fig. 9 A). The timing of these events 
is consistent with accumulation of transcripts that correspond 
to primarily partial  (D~-J~) but  not complete  (V~-D~-J~) 
TCR-/$ rearrangements (Fig.  5) as the former are first de- 
tectable on fetal days 14 and 15 and the latter on days 16 and 
17 (47, 54),  and with the near absence of FL TCR-c~ tran- 
scripts (Fig. 5) as these are first detectable on day 17 of gesta- 
tion (52).  These results additionally suggested that ~'-chain 
overexpression might not affect the development of TCR 3'/8 
thymocytes  because TCR-3" and TCR-8 genes rearrange early 
in fetal ontogeny and TCK 3"/8 + cells are detectable by day 
15 of fetal development (46). In fact, adult thymi from high 
expressing  ~'-FL transgenic mice that were devoid of TCK  + 
o~/~ thymocytes contained normal numbers of TCR + 3"/8 
thymocytes (not shown), a result consistent with the pres- 
ence of abundant TCR-3' and TCR-8 transcripts (Fig.  5). 
Together, these data demonstrate that ~'-mediated downregu- 
lation of RAG-1 and RAG-2 occurs at defined point in thymo- 
cyte development, namely after rearrangement of the TCK-3' 
and TCR-8 genes but prior to complete rearrangement of 
the TCK-o~ and TCK-~ genes. 
Figure  9.  (A) Fetal thymocyte  development  in ~-FL transgenic  mice. 
Thymocytes  were obtained  from fetuses generated  by timed matings of 
Non-Tg males and females  or ~'-FL  (12x) homozygous  males and Non-Tg 
females  (~'-FL  Tg). For each timepoint,  cells from  25-30 thymi  were  com- 
bined and analyzed  by two-color  FCM (columns 1 and 2) or one-color 
FCM (columns  3 and 4). Two-color  histograms  show  staining  of thymo- 
cytes  with FITC  anti-CD4  vs. biotin anti-CD8  plus  TKA. The frequency 
of CD4-CD8 +, CD4+CD8  +, and CD4-CD8-  thymocytes  are indi- 
cated in their respective quadrants. One-color histograms  were obtained 
by staining  with FITC  anti-TCK-B  (column  3) or FITC  anti-CD5  (column 
4). Shaded  areas indicate  staining  with control antibody  (FITC-Leu  4). 
Thymocyte  numbers (No. per thymus x  10 -4) are averages of multiple 
independent timed matings: fd15 (Non-Tg: 13.6, n  =  105; ~'-FL: 14.3, 
n = 101);  fd16 (Non-Tg:  44.5, n = 109; ~'-FL:  22.1, n = 107); fd17  (Non- 
Tg: 164.5, n = 98; ~'-FL: 84.5, n  = 85); fd18 (Non-Tg: 509, n = 30; 
~'-FL: 72.9, n = 24); dl (Non-Tg: 1136, n = 29; ~'-FL: 122.8, n = 20). 
(B) RAG-l, KAG-2, and ~"  expression  in fetal  thymocytes.  Northern  anal- 
Discussion 
The present study demonstrates that overexpression  of FL 
~" chain in early TCR-  o~//3 thymocytes results in down- 
regulation of RAG-1 and RAG-2 transcripts, inhibits com- 
plete rearrangement of the TCR-o~ and TCK-/3 genes and 
blocks entry of thymocytes into the CD4/CD8 developmental 
pathway. These inhibitory effects occur at an identifiable point 
in fetal ontogeny and are dependent upon overexpression  of 
the intact ~" chain as they are not reproduced by overexpres- 
sion of either truncated ~" chains (CT108) or a naturally oc- 
curing splice variant of ~" (7). Moreover, downregulation of 
RAG-1 and RAG-2 correlates with increased surface expres- 
sion of known thymocyte signaling markers such as CD5 
and CD2.  Thus, these results suggest that an early TCR- 
independent signaling mechanism that is differentially respon- 
sive to individual members of the ~'-family of proteins can 
regulate expression of RAG-1 and RAG-2. In addition, they 
provide the first demonstration of different signaling activi- 
ties by the ~" and ~ chains. 
~'chain and related members of the ~'-family dimers (7 and 
FceK13') function in various contexts to couple surface struc- 
tures to intracellular signaling pathways. The recent appreci- 
ation that ~', 7, and 3' differ with respect  to the number of 
functional signaling motifs (3, 2, or 1, respectively)  present 
ysis was performed  with 1 #g of total thymocyte  KNA as described in 
Fig. 5, legend.  Probes consisted  of murine RAG-1 (41), RAG-2 (42), or 
~'-chain cDNAs or human GAPDH cDNA (Clontech  Laboratories  Inc.). 
Exposure times were 6 h (RAG-l, ~', and GAPDH) or 12 h (RAG-2). 
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these proteins may play specialized  roles in ontogeny, per- 
haps by coupling surface receptor complexes to different sig- 
naling responses.  In this study, the transgene encoded ~', ~/, 
and CT108 proteins, which contain identical extracellular and 
transmembrane domains, each promoted the assembly and 
transport of intact TCR od3's to the cell surface.  Because 
these proteins differ only in their cytoplasmic regions, our 
results suggest that the intact ~" chain cytoplasmic tail but 
not the cytoplasmic tail of 77 or CT108, can couple an as yet 
unidentified surface structure(s) to an early signaling response 
that regulates expression of RAG-1 and RAG-2. Whether 
this reflects a specific functional role for 3 TAM repeats or 
for the third TAM, which also overlaps a consensus sequence 
for nucleotide binding (1,  12), remains to be determined. 
The phenotypic effects of FL-~" overexpression are essen- 
tially identical to those that result from TCR-mediated sig- 
naling in immature populations of TCR + thymocytes, in 
that both result in downregulation of RAG-1 and RAG-2 
(24) and enhanced surface expression of CD5 (51). The ob- 
servation that ~" chain can mimic TCR signals  is consistent 
with the previous results of others (13, 16-18), and also demon- 
strates that in thymocytes, ~'is capable of transducing similar 
signals regardless of whether they are initiated by cross-linking 
of the TCR cr/3 complex or by engagement of other pre- 
sumably distinct  ~'-associated surface structures.  In this re- 
spect, it is notable that high levels of ~" chain are detectable 
on the surface of both fetal and adult thymocytes from trans- 
genic mice (our unpublished data). 
Whereas the phenotypic effects of ~" overexpression resemble 
those generated by TCR engagement, they are notably dis- 
tinct from those that result from overexpression of the pro- 
tein tyrosine kinases p561ok and p59~  n, which also participate 
in T cell signaling (55,  56). Overexpression of p56 lck blocks 
complete TCR-/~ rearrangement and entry of thymocytes into 
the CD4/CD8 developmental pathway, but does not inhibit 
TCR-ot rearrangement; and so presumably does not termi- 
nate RAG expression (56). On the other hand, early overex- 
pression of p56 fyn renders thymocytes more responsive to 
TCR-mediated stimulation but does not inhibit normal de- 
velopment (55). That premature downregulation of RAG-1 
and RAG-2 is observed only in mice that overexpress  FL-~" 
chain suggests that  ~" may act as a critical intermediate to 
couple surface structures to a signaling response that con- 
trois expression of these transcripts. 
Our results do not exclude the possibility that ~" chain over- 
expression results in signaling independent of either surface 
expression or association with other surface components. For 
example, it is conceivable that overexpression of ~" could re- 
sult in intracellular signaling during transit through the en- 
doplasmic reticulum and Golgi apparatus; however, sponta- 
neous signaling in established cell lines has not been reported 
in association with overexpression of either ~" or chimeric mol- 
ecules that contain the intact ~" cytoplasmic domain (16, 17). 
It is also possible that the FL ~" chain mediates its effects by 
binding signaling intermediates such as protein tyrosine ki- 
nases via its cytoplasmic tail thereby inhibiting the transduc- 
tion ofintracellular signals. However, such an effect is incon- 
sistent with the observed increase in expression of signaling 
markers such as CD2 and CD5.  Consequently, we think it 
more likely that in early thymocytes, ~" couples surface com- 
plex(es)  other than the intact TCR to an intracellular sig- 
naling pathway that can regulate expression of RAG-1 and 
RAG-2. Various alternative signaling molecules such as Thyl 
and CD2 are expressed on fetal thymocytes and are thought 
to function in early stages of thymocyte development. In ma- 
ture T cells, these molecules can transduce intracellular signals 
when expressed in conjunction with TCR (57, 58). Interest- 
ingly, although truncated ~'chain variants are capable of coup- 
ling the TCR to signal transduction pathways, coexpression 
of TCRs that contain FL ~'chain is required to facilitate efficient 
signaling by Thyl (12-14) and CD2 (14). It has recently been 
proposed that CD16 (Fc'yRIII) may serve a role similar to 
the TCR in fetal thymocytes by coupling accessory mole- 
cules such as Thyl and CD2 to signal transduction pathways 
(59).  CD16,  which is expressed prior to the TCR c~/3 in 
fetal ontogeny, associates with dimers composed of ~" and/or 
FceR13' chains, but assembly with 3' chains is strongly fa- 
vored (10). Consequently, ~'may be effectively excluded from 
associating with CD16 by 3' during normal thymocyte de- 
velopment, resulting in surface expression of a signaling struc- 
ture that does not contain ~'-~"  dimers and that does not ter- 
minate RAG-1  and RAG-2 expression.  Indeed, a possible 
function for  the early expression  of 3'  and  ~  may be  to 
specifically compete with ~" for assembly into surface receptor 
complexes. Overexpression of ~" in transgenic mice could in- 
stead result in surface expression of ~'-~'-associated signaling 
complexes that can downregulate RAG-1 and RAG-2. Thus, 
the outcome of thymocyte development may critically de- 
pend upon competition between members of the ~'-family 
dimers for assembly with surface receptor complexes that are 
expressed on early thymocytes. 
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